The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiency

We report the results of in vitro expression and biochemical characterization of the naturally occurring type II mutation Pro303Thr (P303T) in the factor VII (FVII) gene. Recombinant activated mutated FVII (FVIIa303T), compared with the activated wild‐type FVII (FVIIaWT), showed reduced amidase activity toward synthetic substrates, especially when the observed reduced binding affinity for human soluble tissue factor (TF) (Kd from 4·4 nmol/l for FVIIaWT to 17·3 nmol/l for FVIIa303T) was overcome by a fully saturating TF concentration. Likewise, factor X (FX) hydrolysis by FVIIa303T showed a reduced activity in the absence (and more severely in the presence) of TF (kcat/Km from 2·3 × 107/mol/l s for FVIIaWT to 8·7 × 105/mol/l s for FVIIa303T). These results showed that the mutant FVIIa is more shifted toward a zymogen‐like form compared to FVIIaWT, suggesting that P303 facilitates the conformational transitions that stabilize the active form of FVIIa. The alteration of these allosteric equilibria is especially evident in the presence of TF, which was unable to shift the equilibrium toward a fully active FVIIa form. Additional experiments showed that both TF‐catalysed FVII303T autoactivation and FVII303T activation by activated FX in the presence of TF were severely impaired, mainly because of an increase of the Km value. Altogether, these defects may explain the severe bleeding symptoms in a patient carrying the FVIIP303T mutation.

[1]  P. Mannucci,et al.  Two Naturally Occurring Mutations on FVII Gene (S363I-W364C) Altering Intrinsic Catalytic Activity , 2002, Thrombosis and Haemostasis.

[2]  R. Huber,et al.  Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions. , 2002, Journal of molecular biology.

[3]  O. Olsen,et al.  Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Dwyer,et al.  A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors. , 2001, Biochemistry.

[5]  O. Olsen,et al.  Substitution of Valine for Leucine 305 in Factor VIIa Increases the Intrinsic Enzymatic Activity* , 2001, The Journal of Biological Chemistry.

[6]  M. Dennis,et al.  Selection and characterization of a new class of peptide exosite inhibitors of coagulation factor VIIa. , 2001, Biochemistry.

[7]  M. Ultsch,et al.  The factor VII zymogen structure reveals reregistration of beta strands during activation. , 2001, Structure.

[8]  W Ruf,et al.  Residue Met156 Contributes to the Labile Enzyme Conformation of Coagulation Factor VIIa* , 2001, The Journal of Biological Chemistry.

[9]  O. Olsen,et al.  Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor. , 2001, Biochemistry.

[10]  S. Perkins,et al.  Abnormal secretion and function of recombinant human factor VII as the result of modification to a calcium binding site caused by a 15-base pair insertion in the F7 gene. , 2001, Blood.

[11]  A. Mumford,et al.  Factor VII deficiency and the FVII mutation database , 2001, Human mutation.

[12]  S. Perkins,et al.  Molecular Characterisation and Three-Dimensional Structural Analysis of Mutations in 21 Unrelated Families with Inherited Factor VII Deficiency , 2000, Thrombosis and Haemostasis.

[13]  M. Dwyer,et al.  Peptide exosite inhibitors of factor VIIa as anticoagulants , 2000, Nature.

[14]  A M Brzozowski,et al.  Structure of human factor VIIa and its implications for the triggering of blood coagulation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Furie,et al.  The Biology of P-Selectin Glycoprotein Ligand-1: Its Role as a Selectin Counterreceptor in Leukocyte-Endothelial and Leukocyte-Platelet Interaction , 1999, Thrombosis and Haemostasis.

[16]  S. Iwanaga,et al.  Molecular interaction between factor VII and tissue factor. , 1998, International journal of hematology.

[17]  S. Iwanaga,et al.  Conformation of factor VIIa stabilized by a labile disulfide bond (Cys-310-Cys-329) in the protease domain is essential for interaction with tissue factor. , 1999, The Journal of biological chemistry.

[18]  S. Iwanaga,et al.  Conformation of Factor VIIa Stabilized by a Labile Disulfide Bond (Cys-310–Cys-329) in the Protease Domain Is Essential for Interaction with Tissue Factor* , 1997, The Journal of Biological Chemistry.

[19]  W. Ruf,et al.  Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  O. Olsen,et al.  Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy , 1996, Protein science : a publication of the Protein Society.

[21]  A. Arbini,et al.  A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule. , 1996, Blood.

[22]  David W. Banner,et al.  The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.

[23]  A. Kolstø,et al.  Cell biology of tissue factor, the principal initiator of blood coagulation. , 1996, Thrombosis research.

[24]  H. Saito,et al.  Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304-->Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. , 1994, The Journal of biological chemistry.

[25]  P. Neuenschwander,et al.  Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. , 1993, The Journal of biological chemistry.

[26]  S Krishnaswamy,et al.  The interaction of human factor VIIa with tissue factor. , 1992, The Journal of biological chemistry.

[27]  N. Mackman,et al.  The Structural Biology of Expression and Function of Tissue Factor , 1991, Thrombosis and Haemostasis.

[28]  G. Miller,et al.  Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. , 1991, Blood.

[29]  G. Miller,et al.  Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. , 1991, Blood.

[30]  K. Kurachi,et al.  Characterization of a cDNA coding for human factor VII. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Miletich,et al.  Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII. , 1985, The Journal of clinical investigation.

[32]  S. Rapaport,et al.  Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. , 1981, The Journal of biological chemistry.

[33]  L. Chasin,et al.  Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Y. Nemerson,et al.  Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor. , 1977, The Journal of biological chemistry.

[35]  B. Osterud,et al.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[36]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[37]  D. Small,et al.  Phase equilibria and structure of dry and hydrated egg lecithin. , 1967, Journal of lipid research.

[38]  molecular characterization and , 2022 .